Table 3 Characteristics of Second Recurrent HCCs in the Low- and High- risk Groups
Characteristics | Low Risk | High Risk | ||||
|---|---|---|---|---|---|---|
Short interval | Long interval | P-valve | Short interval | Long interval | P-value | |
n = 11 | n = 35 | n = 54 | n = 70 | |||
Tumor diameter (mm) | 16.73 ± 10.45 | 17.79 ± 10.61 | 0.773 | 19.03 ± 14.34 | 21.56 ± 20.66 | 0.443 |
SrBCLC stage | 0.338 | 0.872 | ||||
0/A | 11 (100.0) | 29 (82.9) | 42 (77.8) | 56 (80.0) | ||
B | 0 (0.0) | 2 (5.7) | 7 (13.0) | 7 (10.0) | ||
C | 0 (0.0) | 4 (11.4) | 5 (9.3) | 7 (10.0) | ||
Location | 0.640 | 0.358 | ||||
Left lobe | 2 (18.2) | 8 (22.9) | 13 (24.1) | 13 (18.6) | ||
Right lobe | 8 (72.7) | 19 (54.3) | 31 (57.4) | 41 (58.6) | ||
Left and right lobes | 1 (9.1) | 5 (14.3) | 7 (13.0) | 6 (8.6) | ||
Metastasis | 0 (0.0) | 3 (8.6) | 3 (5.6) | 10 (14.3) | ||
FrSrDistance (mm) | 41.18 ± 40.39 | 45.70 ± 34.92 | 0.720 | 45.29 ± 31.05 | 49.08 ± 32.37 | 0.513 |
Local recurrence | 1.000 | 0.842 | ||||
Yes | 4 (36.4) | 11 (31.4) | 19 (35.2) | 27 (38.6) | ||
No | 7 (63.6) | 24 (68.6) | 35 (64.8) | 43 (61.4) | ||
Curative treatment | 0.686 | 0.967 | ||||
Yes | 8 (72.7) | 21 (60.0) | 29 (53.7) | 39 (55.7) | ||
No | 3 (27.3) | 14 (40.0) | 25 (46.3) | 31 (44.3) | ||